Skip to main navigation Skip to search Skip to main content

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLELGROUP,MULTICENTER, FIXED-DOSE CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF CARIPRAZINE IN PATIENTS WITH BIPOLAR I DEPRESSION

Project: Research

Project Details

StatusFinished
Effective start/end date07/20/16 → 07/30/18

Funding

  • Forest Research Institute Incorporated: $9,500.00